According to the official website of the Eurasian Patent Office (EAPO), the first national patent.

The new Federal law will enter into force on 18 October 2022. The amendments provide for the possibility to challenge extension of a patent related to a medicine, pesticide, or agrochemical (granting SPCs) by filing an opposition with Rospatent according to procedure set out in Article 1398 (2) of the Russian Civil Code if conditions for such patent extension, stipulated in Article 1363 (2) of the Russian Civil Code, have been violated.

Despite the fact that it is possible to obtain a single Eurasian patent by filing an application with the Eurasian Patent Organization (EAPO), the challenge of such patent is proceed separately in each country party of the Eurasian Patent Convention (excluded an administrative annulment of a patent under art. 19(xiii) of the Eurasian Patent Convention and Rule 53 of the Regulations to the Eurasian Patent Convention).

Ministry of Economic Development published a Letter from 19.07.2022 No. 26614 – KM/D01i “On the elaboration of the Decree of the Russian President No. 322 from 27.05.2022” on its official website.

On 5 July 2022 the State Duma approved in the third reading a draft law No. 11662-8 “On amendments to art. 6 of the Federal Law “On trade secrets” and art. 45 of the Federal Law “On medicines circulation”, under which the Ministry of Industry and Trade will be granted access to trade secrets of medicines ьmanufacturing.

The Ministry of Industry and Trade partially legalized parallel import in Russia by approving the Decree No. 1532 of 19 April 2022 “On goods admissible for parallel import, that shall not be restricted by art. 1359(6) and 1487 of the Civil Code” . The list includes well-known brands of cars, home equipment, smartphones, etc.

On June 21, 2022 State Duma approved in the third hearing a draft law No. 127049-8 “On amendments to the article 18 of the Federal Law “On amendments to certain legislative acts of the Russian Federation”, which eliminates the possibility of civil, administrative and criminal liability for parallel import of goods.

The Russian Government adopted Regulation No. 947 “On the use of an invention to produce of a medicine in the Russian Federation for its further export without the patentholder consent” on 25 May 2022. The Regulation establishes the procedure for issuing export licenses, as well as the methodology for calculation of the sum of compensation to patentholders.

Decree of the Russian President No. 322 "On the Temporary Procedure of Performance of Obligations to Certain Rights Holders" entered into force on 27 May 2022.

The Draft Order of the Russian Ministry of Healthcare on multiagency commission on the detection of medicines shortage or a risk of shortage was published on the official website for draft regulatory acts.